In The News: School of Integrated Health Sciences
Diabetes turns out to be one of the factors in the development of Alzheimer's disease. One of the main features of diabetes - hyperglycemia - is responsible for alzheimer's-like changes.
A study by neuroscientists at the University of Nevada Las Vegas (UNLV) showed that chronic hyperglycemia also impairs memory.
University of Nevada, Las Vegas (UNLV) neuroscientists report on study findings purportedly strengthening the link between Type 2 diabetes and Alzheimer’s disease.
UNLV just held a class in the school of hard knocks.
A team of UNLV neuroscientists has strengthened the link between Type II diabetes and Alzheimer’s disease.
A team of UNLV neuroscientists has strengthened the link between Type II diabetes and Alzheimer’s disease.
A team of UNLV neuroscientists has strengthened the link between Type II diabetes and Alzheimer’s disease.
A team of UNLV neuroscientists has strengthened the link between Type II diabetes and Alzheimer's disease.
Neuroscientists show that chronic hyperglycemia affects fundamental aspects of memory.
In a new study from the University of Nevada, Las Vegas, researchers confirmed the link between type 2 diabetes and Alzheimer’s disease.
Eisai and Biogen announced that Eisai has initiated a rolling submission to the US Food and Drug Administration (FDA) of a Biologics License Application (BLA) for lecanemab (BAN2401), the company’s investigational anti-amyloid beta (Aß) protofibril antibody, for the treatment of early Alzheimer’s disease (early AD).
Optimistic about the drug’s efficacy, the company has initiated its submission for accelerated FDA approval.